Philippe Pouletty is a French entrepreneur and businessperson who founded 14 companies, which include: SangStat Medical Corp., Carmat SA and Vexim SA and who has been the head of 9 different companies.
He is Chairman of Nanosive SASU (which he founded in 2017), Chairman for Abivax SA (which he founded in 2013) and Chief Executive Officer & Director at Truffle Capital SAS (which he founded in 2010). Dr. Pouletty is also Manager of Nakostech SARL and on the board of 15 other companies.
In his past career Philippe Pouletty held the position of Director at France Biotech Association (he founded the company in 2001), Member of Conseil Stratégique pour l'Innovation, Non-Executive Chairman of Bmd SA, Member of Strategic Council on Business Attractiveness, Chairman at Splicos SAS, Chairman at SangStat Medical Corp. (he founded the company in 1988), Director at Drugabuse Sciences, Inc., Director at Wittycell SAS, Director at Vexim SA and Director at Plasmaprime SAS.
He received a doctorate from Université Pierre et Marie Curie.